Cargando…

Schizophrenia and substance use comorbidity: a genome-wide perspective

Dual diagnosis with substance use disorders (SUDs) consistently contributes to the premature mortality and increased disability observed in schizophrenia. Large genome-wide association studies are providing the information needed to investigate the genetic architecture of psychiatric disorders. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polimanti, Renato, Agrawal, Arpana, Gelernter, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359801/ https://www.ncbi.nlm.nih.gov/pubmed/28327175 http://dx.doi.org/10.1186/s13073-017-0423-3

Ejemplares similares

Deciphering the Biological Mechanisms Underlying the Genome-Wide Associations between Computerized Device Use and Psychiatric Disorders
por: Wendt, Frank R, et al.
Publicado: (2019)

Phenome-wide association study for CYP2A6 alleles: rs113288603 is associated with hearing loss symptoms in elderly smokers
por: Polimanti, Renato, et al.
Publicado: (2017)

Multivariate genome-wide analysis of education, socioeconomic status, and brain phenome
por: Wendt, Frank R., et al.
Publicado: (2020)

Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder
por: Polimanti, Renato, et al.
Publicado: (2017)

Schizophrenia and the dynamic genome
por: Sullivan, Patrick F.
Publicado: (2017)

Drinking and smoking polygenic risk is associated with childhood and early-adulthood psychiatric and behavioral traits independently of substance use and psychiatric genetic risk
por: De Angelis, Flavio, et al.
Publicado: (2021)

A commentary: Do specific gene risk variants for schizophrenia contribute similarly to the incidence of schizophrenia world-wide?
por: DeLisi, Lynn E.
Publicado: (2017)

Local adaptation in European populations affected the genetics of psychiatric disorders and behavioral traits
por: Polimanti, Renato, et al.
Publicado: (2018)

Increased Risk of Multiple Outpatient Surgeries in African-American Carriers of Transthyretin Val122Ile Mutation Is Modulated by Non-Coding Variants
por: Polimanti, Renato, et al.
Publicado: (2019)

Substance use and common contributors to morbidity: A genetics perspective
por: Sanchez-Roige, Sandra, et al.
Publicado: (2022)

Polygenic risk for autism spectrum disorder associates with anger recognition in a neurodevelopment-focused phenome-wide scan of unaffected youths from a population-based cohort
por: Wendt, Frank R., et al.
Publicado: (2020)

Heterogeneity and Polygenicity in Psychiatric Disorders: A Genome-Wide Perspective
por: Wendt, Frank R., et al.
Publicado: (2020)

Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci
por: Deak, Joseph D., et al.
Publicado: (2022)

Phenomic Impact of Genetically-Determined Euthyroid Function and Molecular Differences between Thyroid Disorders
por: Ravera, Silvia, et al.
Publicado: (2018)

A genome-wide gene-by-trauma interaction study of alcohol misuse in two independent cohorts identifies PRKG1 as a risk locus
por: Polimanti, Renato, et al.
Publicado: (2017)

Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
por: Volkow, Nora D.
Publicado: (2009)

Morbidity and mortality in schizophrenia with comorbid substance use disorders
por: Lähteenvuo, Markku, et al.
Publicado: (2021)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
por: Lähteenvuo, M., et al.
Publicado: (2021)

Genetic and epigenetic analysis of schizophrenia in blood—a no-brainer?
por: Jaffe, Andrew E., et al.
Publicado: (2016)

Evidence of Polygenic Adaptation in the Systems Genetics of Anthropometric Traits
por: Polimanti, Renato, et al.
Publicado: (2016)

PHENOME-WIDE GENETIC CORRELATION AND CAUSALITY OF COVID-19 SEVERITY HIGHLIGHTS OVERLAP WITH SUBSTANCE-USE TRAITS
por: Pathak, Gita, et al.
Publicado: (2021)

Genome-Wide Investigation of Maximum Habitual Alcohol Intake in US Veterans in Relation to Alcohol Consumption Traits and Alcohol Use Disorder
por: Deak, Joseph D., et al.
Publicado: (2022)

Genome-wide association study of psychiatric and substance use comorbidity in Mexican individuals
por: Martínez-Magaña, José Jaime, et al.
Publicado: (2021)

Genome-Wide Association Study of Opioid Cessation
por: Cox, Jiayi W., et al.
Publicado: (2020)

COVID-19 vaccine effectiveness in people with substance use disorder
por: Huang, Yueqin
Publicado: (2023)

Demographic and Clinical Correlates of Substance Abuse Comorbidity in Schizophrenia
por: Aich, Tapas K., et al.
Publicado: (2004)

Striatal Dopamine Release in Schizophrenia Comorbid with Substance Dependence
por: Thompson, Judy L., et al.
Publicado: (2012)

Telemedicine for treating mental health and substance use disorders: reflections since the pandemic
por: Busch, Alisa B., et al.
Publicado: (2021)

Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden
por: Lähteenvuo, M., et al.
Publicado: (2021)

Migraine genetics: from genome-wide association studies to translational insights
por: Gormley, Padhraig, et al.
Publicado: (2016)

15 years of genome-wide association studies and no signs of slowing down
por: Loos, Ruth J. F.
Publicado: (2020)

Neuroethics at the interface of machine learning and schizophrenia
por: McFarlane, Jacob, et al.
Publicado: (2020)

If there is not one cure for schizophrenia, there may be many
por: Seah, Carina, et al.
Publicado: (2020)

Congenital heart disease and the risk of cancer: The importance of understanding associated comorbidities
por: Mejia, Erika J., et al.
Publicado: (2022)

Perspectives on the expansion of human precision oncology and genomic approaches to sea turtle fibropapillomatosis
por: Duffy, David J., et al.
Publicado: (2019)

Functional and molecular characterization of suicidality factors using phenotypic and genome-wide data
por: Quintero Reis, Andrea, et al.
Publicado: (2023)

Engaging youth as leaders and partners can improve substance use prevention: a call to action to support youth engagement practice and research
por: Ballard, Parissa J., et al.
Publicado: (2023)

Genome-wide association study identifies glutamate ionotropic receptor GRIA4 as a risk gene for comorbid nicotine dependence and major depression
por: Zhou, Hang, et al.
Publicado: (2018)

Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits
por: Zhou, Hang, et al.
Publicado: (2020)

Advanced monitoring of harmful substances and their effects in the Baltic Sea is desired: A comment on Kanwischer et al. (2021)
por: Kankaanpää, Harri T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9g1dqc7n61g4h24v5dtvc690vd